These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19624287)

  • 1. Efficacy of amoxicillin bearing microsphere formulation in treatment of Listeria monocytogenes infection in Swiss albino mice.
    Farazuddin M; Alam M; Khan AA; Khan N; Parvez S; Dutt GU; Mohammad O
    J Drug Target; 2010 Jan; 18(1):45-52. PubMed ID: 19624287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amoxicillin-bearing microparticles: potential in the treatment of Listeria monocytogenes infection in Swiss albino mice.
    Farazuddin M; Chauhan A; Khan RM; Owais M
    Biosci Rep; 2011 Aug; 31(4):265-72. PubMed ID: 20687896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres.
    Xu Q; Czernuszka JT
    J Control Release; 2008 Apr; 127(2):146-53. PubMed ID: 18325617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
    Klose D; Siepmann F; Elkharraz K; Siepmann J
    Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.
    Crotts G; Park TG
    J Microencapsul; 1998; 15(6):699-713. PubMed ID: 9818948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
    Doan TV; Olivier JC
    Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
    He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
    Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
    Bae SE; Son JS; Park K; Han DK
    J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor.
    Li SH; Cai SX; Liu B; Ma KW; Wang ZP; Li XK
    Acta Pharmacol Sin; 2006 Jun; 27(6):754-9. PubMed ID: 16723096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
    Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
    J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice.
    Murata N; Takashima Y; Toyoshima K; Yamamoto M; Okada H
    J Control Release; 2008 Mar; 126(3):246-54. PubMed ID: 18215787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protein/antibiotic releasing poly(lactic-co-glycolic acid)/lecithin scaffold for bone repair applications.
    Shi X; Wang Y; Ren L; Huang W; Wang DA
    Int J Pharm; 2009 May; 373(1-2):85-92. PubMed ID: 19429292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
    Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
    Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
    Lavi G; Voronov E; Dinarello CA; Apte RN; Cohen S
    J Control Release; 2007 Nov; 123(2):123-30. PubMed ID: 17900737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluations of PLGA microsphere vaccine formulations containing pDNA coexpressing hepatitis B surface antigen and Interleukin-2.
    Eratalay A; Coşkun-Ari FF; Oner F; Ozcengīz E
    J Microencapsul; 2010; 27(1):48-56. PubMed ID: 19545223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin.
    Lecároz C; Blanco-Prieto MJ; Burrell MA; Gamazo C
    J Antimicrob Chemother; 2006 Sep; 58(3):549-56. PubMed ID: 16799160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
    Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
    Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.